| Wang Z, Gao R, Shi Q, et al.
Inhibitory effects of NO-fluvastatin on proliferation of human lens epithelial cells in vitro by modulating cell cycle regulatory proteins. [Journal Article]
J Huazhong Univ Sci Technolog Med Sci 2008 Oct; 28(5):588-91.
Abstract | Full Citation | | Obata T, Yonemoti H, Aomine M
The protective effect of fluvastatin on hydroxyl radical generation by inhibiting low-density lipoprotein (LDL) oxidation in the rat myocardium. [JOURNAL ARTICLE]
Microvasc Res 2008 Sep 18.
Abstract | Full Citation | | Colman E, Szarfman A, Wyeth J, et al.
An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system. [JOURNAL ARTICLE]
Pharmacoepidemiol Drug Saf 2008 Sep 29.
Abstract | Full Citation | | Pasanen MK, Miettinen TA, Gylling H, et al.
Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate. [JOURNAL ARTICLE]
Pharmacogenet Genomics 2008 Oct; 18(10):921-926.
Abstract | Full Citation | | Trung TQ, Dung PT, Hoan NN, et al.
Chiral separation of fluvastatin enantiomers by capillary electrophoresis. [JOURNAL ARTICLE]
Arch Pharm Res 2008 Aug; 31(8):1066-1072.
Abstract | Full Citation | Find Related Articles | | Bader T
Reply to Dr Goldstein about HCV and Fluvastatin: Less Armchair and More Science. [JOURNAL ARTICLE]
Am J Gastroenterol 2008 Sep 11.
Full Citation | Find Related Articles | | Couvert P, Giral P, Dejager S, et al.
Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy. [JOURNAL ARTICLE]
Pharmacogenomics 2008 Sep; 9(9):1217-1227.
Abstract | Full Citation | Find Related Articles | | Hu YF, Chen YC, Cheng CC, et al.
Fluvastatin Reduces Pulmonary Vein Spontaneous Activity Through Nitric Oxide Pathway. [JOURNAL ARTICLE]
J Cardiovasc Electrophysiol 2008 Sep 3.
Abstract | Full Citation | | Liska B, Khattab AA, Herrmann L, et al.
Simvastatin and Ezetimibe in Addition to Nonpharmacological Risk Factor Modification for Achieving New Low-Density Lipoprotein Cholesterol Targets. [JOURNAL ARTICLE]
Herz 2008 Jul; 33(5):362-367.
Abstract | Full Citation | | López-Aguilar E, Sepúlveda-Vildósola AC, Betanzos-Cabrera Y, et al.
Phase II Study of Metronomic Chemotherapy with Thalidomide, Carboplatin-Vincristine-Fluvastatin in the Treatment of Brain Stem Tumors in Children. [JOURNAL ARTICLE]
Arch Med Res 2008 Oct; 39(7):655-662.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
